Abstract
Drosophila tumor suppressor WARTS (Wts) is an evolutionally conserved serine / threonine kinase and participates in a signaling complex that regulates both proliferation and apoptosis to ensure the proper size and shape of the fly. Human counterparts of this complex have been found to be frequently downregulated or mutated in cancers. WARTS, a human homolog of Wts, is also known as tumor suppressor and mitotic regulator, but its molecular implications in tumorigenesis are still obscure. Here, we show that WARTS binds via its C-terminus to the PDZ domain of a proapoptotic serine protease Omi / HtrA2. Depletion of WARTS inhibited Omi / HtrA2-mediated cell death, whereas overexpression of WARTS promoted this process. Furthermore, WARTS can enhance the protease activity of Omi / HtrA2 both in vivo and in vitro. Activation of Omi / HtrA2-mediated cell death is thus a potential mechanism for the tumor suppressive activity of WARTS.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Abrams JM . (2002). Cell, 110, 403–406.
Brummelkamp TR, Bernards R and Agami R . (2002). Science, 296, 550–553.
Cilenti L, Soundarapandian MM, Kyriazis GA, Stratico V, Singh S, Gupta S, Bonventre JV, Alnemri ES and Zervos AS . (2004). J. Biol. Chem., 279, 50295–50301.
Conlon I and Raff M . (1999). Cell, 96, 235–244.
Cory S and Adams JM . (2002). Nat. Rev. Cancer, 2, 647–656.
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K and Tuschl T . (2001). Nature, 411, 494–498.
Evan GI, Brown L, Whyte M and Harrington E . (1995). Curr. Opin. Cell Biol., 7, 825–834.
Faccio L, Fusco C, Chen A, Martinotti S, Bonventre JV and Zervos AS . (2000). J. Biol. Chem., 275, 2581–2588.
Gray CW, Ward RV, Karran E, Turconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP and Creasy CL . (2000). Eur. J. Biochem., 267, 5699–5710.
Green DR and Evan GI . (2002). Cancer Cell., 1, 19–30.
Harvey KF, Pfleger CM and Hariharan IK . (2003). Cell, 114, 457–467.
Harvey KJ, Lukovic D and Ucker DS . (2000). J. Cell Biol., 148, 59–72.
Hegde R, Srinivasula SM, Zhang Z, Wassell R, Mukattash R, Cilenti L, DuBois G, Lazebnik Y, Zervos AS, Fernandes-Alnemri T and Alnemri ES . (2002). J. Biol. Chem., 277, 432–438.
Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K and Saya H . (2000). J. Cell Biol., 149, 1073–1086.
Hisaoka M, Tanaka A and Hashimoto H . (2002). Lab. Invest., 82, 1427–1435.
Holley CL, Olson MR, Colon-Ramos DA and Kornbluth S . (2002). Nat. Cell Biol., 4, 439–444.
Huse M and Kuriyan J . (2002). Cell, 109, 275–282.
Iida S, Hirota T, Morisaki T, Marumoto T, Hara T, Kuninaka S, Honda S, Kosai K, Kawasuji M, Pallas DC and Saya H . (2004). Oncogene, 23, 5266–5274.
Jones JM, Datta P, Srinivasula SM, Ji W, Gupta S, Zhang Z, Davies E, Hajnoczky G, Saunders TL, Van Keuren ML, Fernandes-Alnemri T, Meisler MH and Alnemri ES . (2003). Nature, 425, 721–727.
Justice RW, Zilian O, Woods DF, Noll M and Bryant PJ . (1995). Genes Dev., 9, 534–546.
Leist M and Jaattela M . (2001). Nat. Rev. Mol. Cell. Biol., 2, 589–598.
Li W, Srinivasula SM, Chai J, Li P, Wu JW, Zhang Z, Alnemri ES and Shi Y . (2002). Nat. Struct. Biol., 9, 436–441.
Makino K, Kuwahara H, Masuko N, Nishiyama Y, Morisaki T, Sasaki J, Nakao M, Kuwano A, Nakata M, Ushio Y and Saya H . (1997). Oncogene, 14, 2425–2433.
Martins LM, Iaccarino I, Tenev T, Gschmeissner S, Totty NF, Lemoine NR, Savopoulos J, Gray CW, Creasy CL, Dingwall C and Downward J . (2002). J. Biol. Chem., 277, 439–444.
Martins LM, Turk BE, Cowling V, Borg A, Jarrell ET, Cantley LC and Downward J . (2003). J. Biol. Chem., 278, 49417–49427.
Morisaki T, Hirota T, Iida S, Marumoto T, Hara T, Nishiyama Y, Kawasuzi M, Hiraoka T, Mimori T, Araki N, Izawa I, Inagaki M and Saya H . (2002). FEBS Lett., 529, 319–324.
Morita S, Kojima T and Kitamura T . (2000). Gene Therapy, 7, 1063–1066.
Nishiyama Y, Hirota T, Morisaki T, Hara T, Marumoto T, Iida S, Makino K, Yamamoto H, Hiraoka T, Kitamura N and Saya H . (1999). FEBS Lett., 459, 159–165.
Pantalacci S, Tapon N and Leopold P . (2003). Nat. Cell Biol., 5, 921–927.
Ryoo HD, Bergmann A, Gonen H, Ciechanover A and Steller H . (2002). Nat. Cell Biol., 4, 432–438.
Salvesen GS and Duckett CS . (2002). Nat Rev. Mol. Cell. Biol., 3, 401–410.
Schmitt CA and Lowe SW . (1999). J. Pathol., 187, 127–137.
Srinivasula SM, Gupta S, Datta P, Zhang Z, Hegde R, Cheong N, Fernandes-Alnemri T and Alnemri ES . (2003). J. Biol. Chem., 278, 31469–31472.
Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes-Alnemri T, Shi Y and Alnemri ES . (2001). Nature, 410, 112–116.
St John MA, Tao W, Fei X, Fukumoto R, Carcangiu ML, Brownstein DG, Parlow AF, McGrath J and Xu T . (1999). Nat. Genet., 21, 182–186.
Sudo T, Ota Y, Kotani S, Nakao M, Takami Y, Takeda S and Saya H . (2001). EMBO J., 20, 6499–6508.
Suzuki Y, Imai Y, Nakayama H, Takahashi K, Takio K and Takahashi R . (2001). Mol. Cell, 8, 613–621.
Suzuki Y, Takahashi-Niki K, Akagi T, Hashikawa T and Takahashi R . (2004). Cell. Death Differ., 11, 208–216.
Tao W, Zhang S, Turenchalk GS, Stewart RA, St John MA, Chen W and Xu T . (1999). Nat. Genet., 21, 177–181.
Tapon N, Harvey KF, Bell DW, Wahrer DC, Schiripo TA, Haber DA and Hariharan IK . (2002). Cell, 110, 467–478.
Trencia A, Fiory F, Maitan MA, Vito P, Barbagallo AP, Perfetti A, Miele C, Ungaro P, Oriente F, Cilenti L, Zervos AS, Formisano P and Beguinot F . (2004). J. Biol. Chem., 279, 46566–46572.
Tsuruta F, Masuyama N and Gotoh Y . (2002). J. Biol. Chem., 277, 14040–14047.
Udan RS, Kango-Singh M, Nolo R, Tao C and Halder G . (2003). Nat. Cell Biol., 5, 914–920.
Verhagen AM, Silke J, Ekert PG, Pakusch M, Kaufmann H, Connolly LM, Day CL, Tikoo A, Burke R, Wrobel C, Moritz RL, Simpson RJ and Vaux DL . (2002). J. Biol. Chem., 277, 445–454.
Wang X . (2001). Genes Dev., 15, 2922–2933.
Wu S, Huang J, Dong J and Pan D . (2003). Cell, 114, 445–456.
Xu T, Wang W, Zhang S, Stewart RA and Yu W . (1995). Development, 121, 1053–1063.
Yang QH, Church-Hajduk R, Ren J, Newton ML and Du C . (2003). Genes Dev., 17, 1487–1496.
Yang X, Yu K, Hao Y, Li DM, Stewart R, Insogna KL and Xu T . (2004). Nat. Cell Biol., 6, 609–617.
Yang Y, Fang S, Jensen JP, Weissman AM and Ashwell JD . (2000). Science, 288, 874–877.
Yoo SJ, Huh JR, Muro I, Yu H, Wang L, Wang SL, Feldman RM, Clem RJ, Muller HA and Hay BA . (2002). Nat. Cell Biol., 4, 416–424.
Acknowledgements
We thank T Kitamura for the pMXpuro vector and Plat-E cells; Y Hata for the pClneoMyc APC expression plasmid; H Kuwahara for recombinant NE-dlg and PSD95 proteins; M Nakajima for helpful discussion; members of the Saya lab for valuable help and suggestions; and members of the Gene Technology Center at Kumamoto University for technical assistance. SK is a postdoctoral fellow of the Japan Society for the Promotion of Science (JSPS). This work was supported by the Research for the Future Program of the Japan Society for the promotion of Science and by a grant for Cancer Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to HS).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Kuninaka, S., Nomura, M., Hirota, T. et al. The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene 24, 5287–5298 (2005). https://doi.org/10.1038/sj.onc.1208682
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208682
Keywords
This article is cited by
-
Interaction of LATS1 with SMAC links the MST2/Hippo pathway with apoptosis in an IAP-dependent manner
Cell Death & Disease (2022)
-
The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway
Cell Death & Differentiation (2017)
-
Ovarian serous carcinomas acquire cisplatin resistance and increased invasion through downregulation of the high-temperature-required protein A2 (HtrA2), following repeated treatment with cisplatin
Medical Oncology (2017)
-
The member of high temperature requirement family HtrA2 participates in neuronal apoptosis after intracerebral hemorrhage in adult rats
Journal of Molecular Histology (2013)
-
The mitochondrial serine protease HtrA2/Omi: an overview
Cell Death & Differentiation (2008)